Hbm Healthcare Investments (Cayman) Ltd. is > 10% Shareholder of Werewolf Therapeutics, Inc.. Currently has a direct ownership of 625,995 shares of HOWL, which is worth approximately $982,812. The most recent transaction as insider was on May 04, 2021, when has been sold 625,995 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 626K
0% 3M change
0% 12M change
Total Value Held $982,812

HBM Healthcare Investments (Cayman) Ltd. Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 04 2021
BUY
Conversion of derivative security
-
625,995 Added 50.0%
625,995 Common Stock

Also insider at

IOBT
IO Biotech, Inc. Healthcare
MLYS
Mineralys Therapeutics, Inc.
HHI

Hbm Healthcare Investments (Cayman) Ltd.

> 10% Shareholder
Grand Cayman, E9

Track Institutional and Insider Activities on HOWL

Follow Werewolf Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HOWL shares.

Notify only if

Insider Trading

Get notified when an Werewolf Therapeutics, Inc. insider buys or sells HOWL shares.

Notify only if

News

Receive news related to Werewolf Therapeutics, Inc.

Track Activities on HOWL